ANDA 76575, held by Teva. Topiramate.
As of Nov 15, 2026, ANDA 76575 (Topiramate), held by Teva, was first approved by FDA on Apr 17, 2009, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 17, 2009 | Original application | Approved | None posted |
| Topiramate15MG · capsule;oral | Topiramate | Discontinued |
| Topiramate25MG · capsule;oral | Topiramate | Discontinued |
| Jan 9, 2024 | Supplement 22Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 20Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 13Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jan 9, 2024 | Supplement 8Labeling · Standard review | Approved | None posted |
| Nov 18, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| Nov 18, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Nov 18, 2014 | Supplement 5Labeling · Standard review | Approved | None posted |
| Nov 18, 2014 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jul 14, 2011 | Supplement 3Labeling | Approved | None posted |
| Oct 30, 2010 | Supplement 2Labeling | Approved | None posted |
| Sep 30, 2009 | Supplement 1Labeling | Approved | None posted |
| Apr 17, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters